NCT06067503 2026-04-13Biomarkers to Detect Endocrine Therapy ResistanceUniversity of Wisconsin, MadisonPhase 2 Recruiting8 enrolled
NCT05919108 2025-09-09Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast CancersVanderbilt-Ingram Cancer CenterPhase 2 Recruiting30 enrolled